Forget Nvidia. These 5 S&P 500 stocks are quietly going all in on AI.
The article argues that investors should look beyond “Mag Seven” AI hype to S&P 500 companies showing documented AI deployment. It cites a dataset of 130 firms and highlights five: Visa (V), Salesforce (CRM), ServiceNow (NOW), Evolent Health (EVH), and Pagaya (PGY), with figures on AI use, acquisitions, and recent valuation/stock moves.
How this was made
The 30-second read
Why it matters
It is a thematic stock-picking piece rather than a catalyst report. The actionable takeaway is relative positioning: investors may reassess AI-related valuation risk for these names versus the Mag Seven, but the text does not introduce new, time-sensitive company events.
Market read
Traders may use the article to refresh a watchlist and relative-value lens for AI adoption, but it does not provide new disclosures that would drive a near-term repricing by itself.
What to watch
Valuation and execution risk are emphasized, but the article does not provide fresh, comparable KPIs (margin impact, loss rates, authorization approval rates, churn) that would let traders quantify whether AI is truly value-accretive now.
Background
The article argues that AI hype has shifted from “builders” to “deployers,” and selects five S&P 500 companies it claims show unusually deep AI commitment in filings, capital allocation, and workforce decisions.
Ticker impact
Article highlights Visa’s quantified AI usage (26,000 employees, 261,000 AI-powered interactions) and warns agentic AI could disrupt checkout.
Likely limited near-term impact; could support a valuation re-rate only if investors believe AI-driven efficiency offsets disruption risk.
The piece is primarily an analytical thesis with no new Visa disclosure date-stamped in the text; it cites existing annual-report style metrics and a conceptual risk.
Salesforce is described as reorganizing around Agentforce, backed by $3B+ acquisitions, while cutting jobs and deploying AI across CRM tools.
Moderate downside risk if investors conclude competitors can deliver faster and cheaper; upside if AI platform execution improves results.
No fresh earnings/guidance or deal terms are newly disclosed in the article; the $3B+ figure and job cuts are used as evidence for an ongoing strategy.
ServiceNow is said to have deployed $10B+ in AI acquisitions in a year, including $2.85B for Moveworks and $7.75B for Armis.
Near-term reaction likely muted unless the market treats the acquisitions as already priced; medium-term depends on whether financial results catch up.
The article provides acquisition sizes and a valuation multiple, but does not present a new print or incremental disclosure beyond what is referenced.
Evolent Health is described as using AI for prior authorization and clinical-decision support, with the stock down 39% over the past year.
Could remain volatile; valuation support may persist if AI improves authorization outcomes, but downside risk remains if payer relationships weaken.
The article is an opinion-driven selection with no new regulatory, contract, or earnings datapoint; the “depends on relationships that can disappear” is qualitative.
Pagaya is described as an AI underwriting engine for consumer lending, with the stock down 45% over the past year and a subprime-adjacent exposure.
Limited immediate catalyst; direction likely tied to credit conditions and whether AI improves loss performance versus expectations.
No new underwriting metrics, loss data, or regulatory/financing event is disclosed; the article mainly argues from prior performance and positioning.
Market effects
Supports a rotation narrative from AI infrastructure hype toward enterprise software, payments, and healthcare administration where AI is claimed to be embedded in operations.
Primarily US S&P 500 names; mentions international/currency risk as an alternative bucket but provides no new regional catalyst.
Reinforces global AI adoption debate, but without new policy, supply-chain, or cross-border regulatory developments.
Counterpoint
The “quietly going all in” framing may overstate disclosure quality and understate that many AI initiatives have not yet translated into measurable financial acceleration.
Key entities
- companyVisa
Payments network with quantified internal AI usage metrics cited in the article.
- companySalesforce
CRM platform reorganized around Agentforce, with AI deployment and job cuts cited.
- companyServiceNow
Enterprise workflow automation company described as funding AI via large acquisitions.
- companyEvolent Health
Healthcare administration/health-tech firm using AI for prior authorization and decision support.
- companyPagaya Technologies
Fintech using AI for consumer-lending underwriting decisions.
